Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jos B Poell

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Bioinformatics (Oxford, England)|January 1, 2019
ACE: absolute copy number estimation from low-coverage whole-genome sequencing dataJos B Poell, Matias Mendeville, Daoud Sie, et al.
Head & Neck|October 22, 2025
Loss of the Y Chromosome in Oral Potentially Premalignant Disorders Predicts Malignant Progression: An Integrative Cross-Species Multi-Cohort Bioinformatic StudyRui Han, Jos B Poell, Cristina Conde-Lopez, et al.
Frontiers in Oral Health|January 20, 2022
At the Crossroads of Molecular Biology and Immunology: Molecular Pathways for Immunological Targeting of Head and Neck Squamous Cell CarcinomaNiels E Wondergem, Dennis N L M Nijenhuis, Jos B Poell, et al.
Molecular Cancer Therapeutics|May 20, 2016
Sensitizing Triple-Negative Breast Cancer to PI3K Inhibition by Cotargeting IGF1RKlaas de Lint, Jos B Poell, Hayssam Soueidan, et al.
Oral Diseases|October 3, 2021
Associations between clinical and histopathological characteristics in oral leukoplakiaIlkay Evren, Elisabeth R Brouns, Jos B Poell, et al.
Oral Diseases|June 29, 2022
Oral leukoplakia classification and staging system with incorporation of differentiated dysplasiaElisabeth R Brouns, Ilkay Evren, Leon J Wils, et al.
Oral Oncology|September 22, 2019
Characterization of a head and neck cancer-derived cell line panel confirms the distinct TP53-proficient copy number-silent subclassAnne M van Harten, Jos B Poell, Marijke Buijze, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 30, 2022
Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant TransformationLeon J Wils, Jos B Poell, Arjen Brink, et al.
Oral Oncology|June 27, 2020
Comprehensive multiparameter genetic analysis improves circulating tumor DNA detection in head and neck cancer patientsSteven W Mes, Arjen Brink, Erik A Sistermans, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 4, 2020
Incorporation of differentiated dysplasia improves prediction of oral leukoplakia at increased risk of malignant progressionLeon J Wils, Jos B Poell, Ilkay Evren, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Bioinformatics (Oxford, England)|January 1, 2019
ACE: absolute copy number estimation from low-coverage whole-genome sequencing dataJos B Poell, Matias Mendeville, Daoud Sie, et al.
Head & Neck|October 22, 2025
Loss of the Y Chromosome in Oral Potentially Premalignant Disorders Predicts Malignant Progression: An Integrative Cross-Species Multi-Cohort Bioinformatic StudyRui Han, Jos B Poell, Cristina Conde-Lopez, et al.
Frontiers in Oral Health|January 20, 2022
At the Crossroads of Molecular Biology and Immunology: Molecular Pathways for Immunological Targeting of Head and Neck Squamous Cell CarcinomaNiels E Wondergem, Dennis N L M Nijenhuis, Jos B Poell, et al.
Molecular Cancer Therapeutics|May 20, 2016
Sensitizing Triple-Negative Breast Cancer to PI3K Inhibition by Cotargeting IGF1RKlaas de Lint, Jos B Poell, Hayssam Soueidan, et al.
Oral Diseases|October 3, 2021
Associations between clinical and histopathological characteristics in oral leukoplakiaIlkay Evren, Elisabeth R Brouns, Jos B Poell, et al.
Oral Diseases|June 29, 2022
Oral leukoplakia classification and staging system with incorporation of differentiated dysplasiaElisabeth R Brouns, Ilkay Evren, Leon J Wils, et al.
Oral Oncology|September 22, 2019
Characterization of a head and neck cancer-derived cell line panel confirms the distinct TP53-proficient copy number-silent subclassAnne M van Harten, Jos B Poell, Marijke Buijze, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 30, 2022
Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant TransformationLeon J Wils, Jos B Poell, Arjen Brink, et al.
Oral Oncology|June 27, 2020
Comprehensive multiparameter genetic analysis improves circulating tumor DNA detection in head and neck cancer patientsSteven W Mes, Arjen Brink, Erik A Sistermans, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 4, 2020
Incorporation of differentiated dysplasia improves prediction of oral leukoplakia at increased risk of malignant progressionLeon J Wils, Jos B Poell, Ilkay Evren, et al.
Pageof 3